Delivery Order 80JSC025DA003-80JSC026FA062
- Not listed
- The University of Colorado, through its Office of Contracts and Grants Division, has been awarded a $3.19 million firm fixed-price delivery order by NASA's Johnson Space Center to develop induced pluripotent stem cell-derived chimeric antigen receptor T-cell (iPSC-derived CAR-T) therapies manufactured in space environments for clinical applications. The work will be performed in Boulder, Colorado, with an ultimate completion date of December 15, 2028. This delivery order is issued under a larger...
- The University of Colorado, through its Office of Contracts and Grants Division, received a $228,018 firm fixed-price delivery order from NASA's Johnson Space Center for scalable commercial biomanufacturing in low earth orbit. Awarded on January 31, 2026, with a completion date of January 30, 2028, this delivery order will be performed in Boulder, Colorado. The award carries no set-aside designation, reflecting the university's competitive standing. This delivery order is issued under a larger...
- The University of Colorado has received a $450,000 firm fixed-price delivery order from NASA's Johnson Space Center to conduct microgravity research aboard the International Space Station. The project involves studying human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) that will be fabricated into physiologically relevant three-dimensional engineered heart tissues (EHTs) and tested in the microgravity environment. The work is scheduled for completion by February 20, 2027, and...
- This is a $420,000.00 firm-fixed-price delivery order contract awarded by the National Aeronautics and Space Administration (NASA) Johnson Space Center to The Regents of the University of Colorado, doing business as the University of Colorado Office of Contracts and Grants Division. The contract is for research on the functional effects of microgravity on cardiac stem cells. The contract was awarded on June 10, 2016 with a completion date of December 31, 2017. The University of Colorado is a...
- The Regents of the University of Colorado, operating through its Office of Contracts and Grants Division, received a $299,834.50 firm fixed-price delivery order from NASA's Johnson Space Center on July 25, 2024, to support research on the effect of metabolic supplements on muscle regeneration under microgravity conditions. Work will be performed in Boulder, Colorado, with an ultimate completion date of February 28, 2026. This delivery order was issued without a set-aside designation,...
- The Regents of the University of Colorado, Boulder, has been awarded a $507,000 firm fixed-price delivery order by NASA's Johnson Space Center to conduct research on the effects of age on the mechanochemical feedback loop for extracellular matrix production by fibroblasts in the context of wound healing. This delivery order, issued on October 12, 2023, is scheduled for completion by February 20, 2027, with performance taking place in Boulder, Colorado. The award carries no set-aside designation,...
- The National Aeronautics and Space Administration (NASA) Johnson Space Center awarded a firm-fixed price delivery order contract to The Regents of the University of Colorado, a U.S. state government educational institution, for research on "Microgravity as Model for Immunological Senescence and its Impact on Tissue Stem Cells and Regeneration". The $597,118.00 contract, which does not have a set-aside designation, is scheduled for completion on November 15, 2022. As a public research...
- This is a firm-fixed price delivery order awarded by the National Aeronautics and Space Administration (NASA) Johnson Space Center to The Regents of the University of Colorado, doing business as the University of Colorado Office of Contracts and Grants Division. The $450,600.00 contract is for a study of mammalian pluripotent stem cells in microgravity, titled "STUDY OF MAMMALIAN PLURIPOTENT STEM CELLS IN MICROGRAVITY (MICRO-15)". The contract has a completion date of March 31, 2020...
- The National Aeronautics and Space Administration Johnson Space Center awarded a $492,000 firm fixed price delivery order contract to The Regents of the University of Colorado, doing business as the University of Colorado Office of Contracts and Grants Division. The contract is for a Role of Mesenchymal Stem Cells in Microgravity Induced Bone Loss mission integration and operations support. The contract has a completion date of September 30, 2024 and was awarded on August 25, 2022 without a...
- This is a Firm Fixed Price delivery order contract awarded by the Johnson Space Center (JSC), a civilian agency, to The Regents of the University of Colorado (CU) for the MISSION INTEGRATION & OPERATIONS FOR THE INVESTIGATION TITLED ROLE OF MESENCHYMAL STEM CELLS IN MICROGRAVITY INDUCED BONE LOSS (MABL-B). The contract has a ceiling value of $507,000.00 and a period of performance through February 20, 2027. This award is not designated as a set-aside contract. CU, a prominent public research...
- 80JSC025DA003Indefinite Delivery Contract
- 80JSC025DA003-80JSC026FA062Delivery Order
The University of Colorado, through its Office of Contracts and Grants Division, received a $1.02 million firm fixed-price delivery order from NASA's Johnson Space Center for Phase 1B research on in-space expansion of hematopoietic stem cells for clinical application. This delivery order, awarded on February 12, 2026, with completion targeted for January 31, 2027, will be performed in Boulder, Colorado. The award was made without set-aside designation, reflecting the university's competitive standing. This delivery order is issued under a larger Indefinite Delivery Contract valued at $15 million with NASA's Johnson Space Center for Low Earth Orbit Space Life Science Research Platform services, which provides the university with a flexible mechanism to deliver specialized research capabilities and mission integration support for NASA's space-based scientific investigations through July 2030. This contract represents a continuation of the University of Colorado's substantial involvement in NASA's life sciences research portfolio, supporting the agency's strategic objective to leverage microgravity environments for advancing biomedical research. The work involves developing hematopoietic stem cell expansion technologies in space, which has significant implications for regenerative medicine and cell therapy manufacturing. As a key partner in NASA's space life science initiatives, the university brings established expertise in microgravity research platforms and cell therapy development, building on prior delivery orders for induced pluripotent stem cell-derived therapies and microgravity payload operations completed under the parent IDV.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $750.0k | 2/12/26 |